We are live on ! Find out more
QEI

QSV Equity Investors Portfolio holdings

AUM $67.6M
1-Year Est. Return 0.29%
This Fund
S&P 500
This Quarter Est. Return
+0.08%
1 Year Est. Return
-0.29%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$96M
AUM Growth
-$645K
Cap. Flow
+$333K
Cap. Flow %
0.35%
Top 10 Hldgs %
22.57%
Holding
95
New
8
Increased
17
Reduced
52
Closed
5

Top Buys

Rank Stock Value
1
HAE icon
Haemonetics
HAE
+$1.38M
2
CBT icon
Cabot Corp
CBT
+$1.23M
3
GNTX icon
Gentex
GNTX
+$1.19M
4
KWR icon
Quaker Houghton
KWR
+$1.16M
5
TNC icon
Tennant Co
TNC
+$1.01M

Top Sells

Rank Stock Value
1
MEDP icon
Medpace
MEDP
+$1.72M
2
NSP icon
Insperity
NSP
+$1.6M
3
CLB icon
Core Laboratories
CLB
+$1.33M
4
HWKN icon
Hawkins
HWKN
+$1.32M
5
SLP icon
Simulations Plus
SLP
+$1.29M

Sector Composition

Rank Sector Weight
1 Financials 25.66%
2 Technology 17.96%
3 Industrials 13.07%
4 Healthcare 11.68%
5 Real Estate 10.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LBRT icon
51
Liberty Energy
LBRT
$3.45B
$1.09M 1.13%
94,528
+15,962
+20% +$193K
TNC icon
52
Tennant Co
TNC
$1.18B
$1.06M 1.1%
+13,646
New +$1.01M
IOSP icon
53
Innospec
IOSP
$2.29B
$1.02M 1.07%
12,165
-142
-1% -$12.4K
ASTH icon
54
Astrana Health
ASTH
$1.86B
$982K 1.02%
39,458
-328
-0.8% -$9.24K
CZNC icon
55
Citizens & Northern Corp
CZNC
$454M
$965K 1.01%
50,933
-433
-0.8% -$8.21K
MGPI icon
56
MGP Ingredients
MGPI
$381M
$952K 0.99%
31,766
+14,028
+79% +$417K
ZD icon
57
Ziff Davis
ZD
$2B
$952K 0.99%
31,434
-265
-0.8% -$8.52K
RLI icon
58
RLI Corp
RLI
$5.83B
$937K 0.98%
12,974
-6,515
-33% -$488K
BRKR icon
59
Bruker
BRKR
$8.58B
$912K 0.95%
+22,143
New +$855K
REYN icon
60
Reynolds Consumer Products
REYN
$5.51B
$883K 0.92%
+41,211
New +$933K
HELE icon
61
Helen of Troy
HELE
$680M
$714K 0.74%
25,142
+5,635
+29% +$173K
MOAT icon
62
VanEck Morningstar Wide Moat ETF
MOAT
$12.4B
$464K 0.48%
4,950
-53
-1% -$4.65K
LH icon
63
Labcorp
LH
$26.1B
$444K 0.46%
1,693
– –
PAYC icon
64
Paycom
PAYC
$9.62B
$441K 0.46%
1,907
-5
-0.3% -$1.19K
ROL icon
65
Rollins
ROL
$17.9B
$392K 0.41%
6,942
– –
SNV
66
DELISTED
Synovus
SNV
$377K 0.39%
7,279
– –
OTIS icon
67
Otis Worldwide
OTIS
$27.7B
$364K 0.38%
3,679
– –
DINO icon
68
HF Sinclair
DINO
$15.2B
$357K 0.37%
8,702
+1,103
+15% +$38K
ZBRA icon
69
Zebra Technologies
ZBRA
$17.9B
$334K 0.35%
1,082
+249
+30% +$67.6K
BR icon
70
Broadridge
BR
$19.8B
$332K 0.35%
1,368
– –
TYL icon
71
Tyler Technologies
TYL
$13B
$327K 0.34%
552
– –
CF icon
72
CF Industries
CF
$18.4B
$315K 0.33%
3,425
– –
JKHY icon
73
Jack Henry & Associates
JKHY
$11B
$302K 0.31%
1,676
+7
+0.4% +$1.24K
CPAY icon
74
Corpay
CPAY
$26.3B
$298K 0.31%
909
-1
-0.1% -$326
JLL icon
75
Jones Lang LaSalle
JLL
$16.4B
$298K 0.31%
1,164
– –
1 2
3
4

Similar funds

BBW
Blue Barn Wealth Orem, Utah $68.7M AUM 16.42% 1-Year Est. Return
YCM
Yost Capital Management Houston, Texas $68.9M AUM 18.32% 1-Year Est. Return
RWA
Redmont Wealth Advisors Chicago, Illinois $66M AUM 13.09% 1-Year Est. Return
KWM
KW Wealth Management Sacramento, California $65.9M AUM
IA
Incentive AS Oslo, Norway $71.3M AUM 30.74% 1-Year Est. Return
MCL
MWG Caph Ltd Charlestown $72.4M AUM
RRCP
Rip Road Capital Partners Boston, Massachusetts $62.5M AUM 1.22% 1-Year Est. Return
BCPEMI
Bain Capital Public Equity Management II Boston, Massachusetts $62.1M AUM 25.46% 1-Year Est. Return

QSV Equity Investors's Q2 2025 Portfolio in Review

As of Q2 2025, QSV Equity Investors held 95 positions worth $96M, down 0.67% from $96.6M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

QSV Equity Investors's Q2 2025 filing shows 8 new, 17 increased, 52 reduced and 5 closed positions. Its largest new stake was Haemonetics: 20,790 shares worth $1.55M. The largest sale was Medpace, an estimated $1.72M.

By sector, the portfolio is most concentrated in Financials at 26% of assets, up from 26% a quarter earlier, followed by Technology and Industrials.

  • QSV Equity Investors's largest Q2 2025 buy was Haemonetics: 20,790 shares worth $1.55M.
  • QSV Equity Investors added most to Gentex in Q2 2025, an estimated $1.19M increase.
  • QSV Equity Investors's biggest Q2 2025 reduction was Catalyst Pharmaceutical, cutting an estimated $718K.
  • QSV Equity Investors fully exited Medpace in Q2 2025, selling an estimated $1.72M.
  • QSV Equity Investors's ten largest holdings make up 23% of its $96M portfolio in Q2 2025.
  • QSV Equity Investors opened 8 new positions and closed 5 in Q2 2025.
  • QSV Equity Investors's portfolio value fell 0.67% quarter-over-quarter to $96M.

Based on QSV Equity Investors's 13F filing for Q2 2025, filed 13 Aug 2025.